Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Change in Account Payables: 2014-2025

Historic Change in Account Payables for Aytu Biopharma (AYTU) over the last 10 years, with Jun 2025 value amounting to $287,000.

  • Aytu Biopharma's Change in Account Payables fell 44.61% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 1021.49%. This contributed to the annual value of $287,000 for FY2025, which is 113.82% up from last year.
  • Latest data reveals that Aytu Biopharma reported Change in Account Payables of $287,000 as of FY2025, which was up 113.82% from -$2.1 million recorded in FY2024.
  • Aytu Biopharma's Change in Account Payables' 5-year high stood at $2.4 million during FY2023, with a 5-year trough of -$7.7 million in FY2022.
  • Its 3-year average for Change in Account Payables is $198,333, with a median of $287,000 in 2025.
  • As far as peak fluctuations go, Aytu Biopharma's Change in Account Payables skyrocketed by 131.04% in 2023, and later crashed by 187.08% in 2024.
  • Over the past 5 years, Aytu Biopharma's Change in Account Payables (Yearly) stood at -$3.2 million in 2021, then crashed by 136.70% to -$7.7 million in 2022, then soared by 131.04% to $2.4 million in 2023, then crashed by 187.08% to -$2.1 million in 2024, then soared by 113.82% to $287,000 in 2025.